• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    More On MSLI



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Merus Labs International Inc. (MSLI)

    1.44 Up 0.04(2.86%) Jan 23, 3:55PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Merus Labs International Inc.
    100 Wellington Street West
    Suite 2110
    Toronto, ON M5K 1H1
    Canada - Map
    Phone: 416-593-3725
    Fax: 416-593-4434
    Website: http://www.meruslabs.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Merus Labs International Inc., a specialty pharmaceutical company, engages in the acquisition and licensing of prescription medicines in the United States, Canada, and Europe. The company offers Emselex/Enablex, a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency; Sintrom, an anti-coagulant drug for the treatment and prevention of clotting disorders like thromboembolism diseases; and Vancocin, an antibiotic used to treat diseases resulting from the infection of Clostridium Difficile. Its customers include national wholesalers, physicians and allied health professionals, patients and their families/caregivers, managed care organizations and group purchasing organizations, and state and federal government health agencies. The company is headquartered in Toronto, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Merus Labs International Inc.

    Key Executives 
    Mr. Andrew P. Patient B.Acc, C.A., 44
    Chief Financial Officer
    Dr. Ulrich Schoeberl ,
    Head of European Operations
    Mr. Barry Fishman ,
    Interim Chief Exec. Officer and Director
    Mr. Bob McLay ,
    VP of M&S Canada
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.